Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$58.85 USD
+0.06 (0.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $58.81 -0.04 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Exact Sciences Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 778 | 632 | 1,030 | 1,840 | 324 |
Receivables | 204 | 158 | 217 | 233 | 131 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 127 | 118 | 105 | 92 | 62 |
Other Current Assets | 86 | 74 | 74 | 33 | 41 |
Total Current Assets | 1,194 | 982 | 1,426 | 2,199 | 557 |
Net Property & Equipment | 698 | 685 | 580 | 451 | 455 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 4,258 | 4,302 | 4,430 | 2,086 | 2,347 |
Deposits & Other Assets | 177 | 91 | 75 | 64 | 20 |
Total Assets | 6,471 | 6,227 | 6,685 | 4,925 | 3,506 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 79 | 75 | 68 | 36 | 26 |
Current Portion Long-Term Debt | 50 | 0 | 0 | 257 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 342 | 299 | 399 | 234 | 193 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 15 | 10 | 31 | 38 | 8 |
Total Current Liabilities | 515 | 413 | 517 | 576 | 236 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 2,314 | 2,186 | 2,180 | 1,321 | 804 |
Long-Term Debt | 0 | 50 | 0 | 22 | 24 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 336 | 352 | 418 | 62 | 35 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,326 | 3,184 | 3,297 | 2,102 | 1,218 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 1 |
Capital Surplus | 6,611 | 6,312 | 6,029 | 4,790 | 3,406 |
Retained Earnings | -3,469 | -3,265 | -2,642 | -1,968 | -1,120 |
Other Equity | 1 | -5 | -1 | 1 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3,145 | 3,043 | 3,388 | 2,823 | 2,288 |
Total Liabilities & Shareholder's Equity | 6,471 | 6,227 | 6,685 | 4,925 | 3,506 |
Total Common Equity | 3,145 | 3,043 | 3,388 | 2,823 | 2,288 |
Shares Outstanding | 180.80 | 177.60 | 172.30 | 150.40 | 129.80 |
Book Value Per Share | 17.40 | 17.13 | 19.66 | 18.77 | 17.63 |
Fiscal Year End for Exact Sciences Corporation falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 778 | 734 | 776 | 699 |
Receivables | NA | 204 | 199 | 178 | 183 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 127 | 133 | 131 | 124 |
Other Current Assets | NA | 86 | 82 | 89 | 85 |
Total Current Assets | NA | 1,194 | 1,148 | 1,174 | 1,091 |
Net Property & Equipment | NA | 698 | 692 | 687 | 685 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 4,258 | 4,280 | 4,257 | 4,280 |
Deposits & Other Assets | NA | 177 | 151 | 90 | 92 |
Total Assets | NA | 6,471 | 6,421 | 6,356 | 6,304 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 79 | 74 | 75 | 87 |
Current Portion Long-Term Debt | NA | 50 | 50 | 50 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 342 | 310 | 300 | 242 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 15 | 13 | 34 | 9 |
Total Current Liabilities | NA | 515 | 477 | 488 | 367 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 2,314 | 2,313 | 2,312 | 2,310 |
Long-Term Debt | NA | 0 | 0 | 0 | 50 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 342 | 331 | 344 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 3,326 | 3,300 | 3,299 | 3,247 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 2 | 2 | 2 | 2 |
Capital Surplus | NA | 6,611 | 6,540 | 6,476 | 6,397 |
Retained Earnings | NA | -3,469 | -3,419 | -3,420 | -3,339 |
Other Equity | NA | 1 | -2 | -1 | -2 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 3,145 | 3,121 | 3,057 | 3,058 |
Total Liabilities & Shareholder's Equity | NA | 6,471 | 6,421 | 6,356 | 6,304 |
Total Common Equity | 0 | 3,145 | 3,121 | 3,057 | 3,058 |
Shares Outstanding | 181.50 | 180.80 | 180.60 | 180.40 | 179.80 |
Book Value Per Share | 0.00 | 17.40 | 17.28 | 16.94 | 17.01 |